DOCSLIB.ORG

Exosomes As Emerging Pro-Tumorigenic Mediators of the Senescence-Associated Secretory Phenotype

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Exosomes As Emerging Pro-Tumorigenic Mediators of the Senescence-Associated Secretory Phenotype International Journal of Molecular Sciences Review Exosomes as Emerging Pro-Tumorigenic Mediators of the Senescence-Associated Secretory Phenotype Rekha Jakhar 1 and Karen Crasta 1,2,3,* 1 Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, 59 Nanyang Drive, Singapore 636921, Singapore; [email protected] 2 School of Biological Sciences, Nanyang Technological University Singapore, 59 Nanyang Drive, Singapore 636921, Singapore 3 Agency of Science, Technology and Research, Institute of Molecular and Cell Biology, Singapore 636921, Singapore * Correspondence: [email protected]; Tel.: +65-65927870 Received: 17 April 2019; Accepted: 7 May 2019; Published: 24 May 2019 Abstract: Communication between cells is quintessential for biological function and cellular homeostasis. Membrane-bound extracellular vesicles known as exosomes play pivotal roles in mediating intercellular communication in tumor microenvironments. These vesicles and exosomes carry and transfer biomolecules such as proteins, lipids and nucleic acids. Here we focus on exosomes secreted from senescent cells. Cellular senescence can alter the microenvironment and influence neighbouring cells via the senescence-associated secretory phenotype (SASP), which consists of factors such as cytokines, chemokines, matrix proteases and growth factors. This review focuses on exosomes as emerging SASP components that can confer pro-tumorigenic effects in pre-malignant recipient cells. This is in addition to their role in carrying SASP factors. Transfer of such exosomal components may potentially lead to cell proliferation, inflammation and chromosomal instability, and consequently cancer initiation. Senescent cells are known to gather in various tissues with age; eliminating senescent cells or blocking the detrimental effects of the SASP has been shown to alleviate multiple age-related phenotypes. Hence, we speculate that a better understanding of the role of exosomes released from senescent cells in the context of cancer biology may have implications for elucidating mechanisms by which aging promotes cancer and other age-related diseases, and how therapeutic resistance is exacerbated with age. Keywords: senescence; SASP; pro-tumourigenic; exosomes; cancer 1. Introduction Cellular senescence is a cellular stress response that culminates in a state of stable cell cycle arrest [1]. As such, it has long been thought to function as an anti-proliferative mechanism against tumor formation in cancers. Senescence has also been strongly associated with age-associated diseases, and has been implicated in developmental processes and wound healing [2]. Cells undergo cellular senescence in response to stressful conditions such as DNA damage, oxidative stress, telomere attrition, oncogenic stress, irradiation and hypoxia. Importantly, the secretion of exosomes has been shown to increase under these conditions [3,4]. This is exciting as exosomes contain proteins, lipids, microRNAs, mRNA and DNA, and can act as “messengers” from one cell to another. This also implies a role for exosomes as senescence effectors. Under stressful conditions, exosomes could relay intercellular cell non-autonomous communication to neighbouring cells and thereby determine the appropriate cell fate response. Int. J. Mol. Sci. 2019, 20, 2547; doi:10.3390/ijms20102547 www.mdpi.com/journal/ijms Int. J. Mol. Sci. 2019, 20, 2547 2 of 17 Int. J. Mol.The Sci. main 2019, focus20, x FOR of PEER this REVIEW review aims to discuss the emerging cell non-autonomous role2 of of17 senescence-derived exosomes and its possible implications for tumorigenesis. We first take a look at 45 exosomal biogenesisbiogenesis andand their their functional functional roles roles upon upon uptake uptake in premalignantin premalignant and and cancer cancer cells. cells. We thenWe 46 thenhighlight highlight the role the of role exosomes of exosomes during during senescence, senescence, with awith key a focus key focus on exosomes on exosomes as constituents as constituents of the 47 ofsenescent the senescent secretome secretome known known as senescence-associated as senescence-associated secretory secretory phenotype phenotype (SASP). (SASP). Lastly, we Lastly, provide we 48 providean overall an perspective overall asperspective well as speculate as well on theas implicationsspeculate on of exosomesthe implications as pro-tumourigenic of exosomes SASP as 49 pro-tumourigenicin the “aging-cancer” SASP nexus. in the “aging-cancer” nexus. 50 2. Exosome Exosome Biogenesis, Composition and Uptake 51 Extracellular vesicles are membrane-bound vesicles released by multiple cell types that include 52 immune cells, prostate epithelialepithelial cells,cells, stemstem cells,cells, cancercancer cells,cells, andand neuronsneurons [5[5].]. These include 53 exosomes, epididymosomes, prostasomes, ectosomes, apoptotic bodies, microvesicles, and more 54 recently oncosomes (Figure 11).). EvenEven thoughthough perplexityperplexity existsexists betweenbetween thethe termterm “exosome”“exosome” andand 55 “microvesicles”,“microvesicles”, these can be distinguished on the basis of their sizes, functional properties and 56 biogenesis (Figure1 1).). 57 58 Figure 1. Origin and biogenesis of different different groups of extracellularextracellular vesicles.vesicles. EVs are arranged by 59 increasing size from left toto right.right. Left- Left- Exosomes, Exosomes, are are secreted secreted by by a a variety variety of of cell types and are 60 formed in MVBs via thethe endocyticendocytic pathway.pathway. Epididymosomes and and Prostasomes are are EVs found in 61 seminal fluid. fluid. Epididymosomes Epididymosomes are are secreted secreted by by cells cells in in the epididymis through budding from the 62 plasma membranemembrane and and prostasomes prostasomes are are secreted secreted by epithelial by epithelial cells of cells the prostateof the glandprostate via gland endosome via 63 endosomeformation andformation release and into release the prostatic into the fluid. prostatic Ectosomes, fluid. Ectosomes, like exosomes, like exosomes, are secreted are by secreted a variety by of a 64 varietycell types of butcell unliketypes but exosomes, unlike exosomes, they are formed they are via formed budding via from budding the plasma from the membrane. plasma membrane. Apoptotic 65 Apoptoticbodies are thebodies results are of the blebs results arising of from blebs disassembly arising from of apoptotic disassembly cells. of They apoptotic are subdivided cells. They into twoare 66 subdividedgroups, depending into two on groups, their contents: depending nuclear on their (DNA contents: carrying) nuclear apoptotic (DNA bodes carrying) (NABs) apoptotic and cytoplasmic bodes 67 (NABs)apoptotic and bodies cytoplasmic (CABs). Microvesiclesapoptotic bodies are larger(CABs). in Microvesicles size and are also are secretedlarger in by size a variety and are of cells.also 68 Theysecreted are alsoby a generated variety of by cells. outward They budding are also from generated the plasma by membrane. outward budding Oncosomes from are muchthe plasma larger 69 membrane.than most extracellular Oncosomes vesicles are much are secretedlarger than by variousmost extracellular cancer cells viavesicles membrane are secreted shedding. by various 70 cancer cells via membrane shedding. Exosomes are basically nano-sized (ranging from 40–100 nm) intercellular communication shuttles. 71 SinceExosomes the discovery are basically of exosomes nano-sized in 1983, (ranging it has become from evident40–100 thatnm) exosomesintercellular contribute communication to many 72 shuttles.aspects of Since physiology the discovery and disease, of exosomes mainly in via1983, cell-to-cell it has become communication evident that [ 5exosomes]. We highlight contribute a few to 73 manyexciting aspects milestones of physiology in the biology and disease, of exosome mainly research via cell-to-cell in Figure2 communication. [5]. We highlight a 74 few exciting milestones in the biology of exosome research in Figure 2. Int. J. Mol. Sci. 2019, 20, 2547 3 of 17 Int. J. Mol. Sci. 2019, 20, x FOR PEER REVIEW 3 of 17 Int. J. Mol. Sci. 2019, 20, x FOR PEER REVIEW 3 of 17 75 Figure 2. Historic landmarks for the discovery and application of exosomes. Chronological summary 76 Figure 2. Historic landmarks for the discovery and application of exosomes. Chronological summary 77 of75of the the key key events events that that led led to to the the discovery discovery andand applicationapplication of exosomes exosomes and and EVs EVs from from 1983 1983 to to2016. 2016. Exosome76 Figure biogenesis 2. Historic begins landmarks with for inwardthe discovery budding and application of the of cellular exosomes. plasma Chronological membrane summary to form early 78 77Exosome of thebiogenesis key events thatbegins led to thewith discovery inward and buddingapplication ofof exosomes the cellular and EVs plasma from 1983 membrane to 2016. to form 79 endosomes.early endosomes. Inward Inward budding budding of this endosomalof this endosomal membrane membrane then forms then late forms endosomes late endosomes containing 78 80 intraluminalcontaining intraluminal vesiclesExosome (Figurebiogenesis vesicles3). begins These(Figure with endosomes 3). inward These budding endosomes are referredof the are cellular toreferred as plasma multivesicular to asmembrane multivesicular to bodies form bodies (MVBs) 79 early endosomes. Inward budding of this endosomal membrane then forms late endosomes 81 and(MVBs) contain and multiple containvesicles
Load more

Recommended publications
  • Role of Microbiota-Derived Extracellular Vesicles in Gut-Brain Communication
    International Journal of Molecular Sciences Review Role of Microbiota-Derived Extracellular Vesicles in Gut-Brain Communication Carlos M. Cuesta 1, Consuelo Guerri 1 , Juan Ureña 1 and María Pascual 1,2,* 1 Department of Molecular and Cellular Pathology of Alcohol, Príncipe Felipe Research Center, 46012 Valencia, Spain; [email protected] (C.M.C.); [email protected] (C.G.); [email protected] (J.U.) 2 Department of Physiology, School of Medicine and Dentistry, University of Valencia, Avda. Blasco Ibáñez, 15, 46010 Valencia, Spain * Correspondence: [email protected] or [email protected]; Tel.: +34-961-625-635; Fax: +34-963-864-642 Abstract: Human intestinal microbiota comprise of a dynamic population of bacterial species and other microorganisms with the capacity to interact with the rest of the organism and strongly influence the host during homeostasis and disease. Commensal and pathogenic bacteria coexist in homeostasis with the intestinal epithelium and the gastrointestinal tract’s immune system, or GALT (gut-associated lymphoid tissue), of the host. However, a disruption to this homeostasis or dysbiosis by different factors (e.g., stress, diet, use of antibiotics, age, inflammatory processes) can cause brain dysfunction given the communication between the gut and brain. Recently, extracellular vesicles (EVs) derived from bacteria have emerged as possible carriers in gut-brain communication through the interaction of their vesicle components with immune receptors, which lead to neuroinflammatory immune response activation. This review discusses the critical role of bacterial EVs from the gut in the neuropathology of brain dysfunctions by modulating the immune response. These vesicles, which contain harmful bacterial EV contents such as lipopolysaccharide (LPS), peptidoglycans, toxins and Citation: Cuesta, C.M.; Guerri, C.; nucleic acids, are capable of crossing tissue barriers including the blood-brain barrier and interacting Ureña, J.; Pascual, M.
    [Show full text]
  • Extracellular Vesicle Proteomes Reflect Developmental Phases of Bacillus Subtilis Yeji Kim1, Nathan Edwards2 and Catherine Fenselau1*
    Kim et al. Clin Proteom (2016) 13:6 DOI 10.1186/s12014-016-9107-z Clinical Proteomics RESEARCH Open Access Extracellular vesicle proteomes reflect developmental phases of Bacillus subtilis Yeji Kim1, Nathan Edwards2 and Catherine Fenselau1* Abstract Background: Extracellular vesicles (EV) are spherical membrane-bound vesicles with nano-scale diameters, which are shed to the extracellular region by most eukaryotic and prokaryotic cells. Bacterial EV are proposed to contribute to intercellular communication, bacterial survival and human pathogenesis as a novel secretion system. EV have been characterized from many Gram-negative species and, more recently, from several vegetative Gram-positive bacteria. Further characterization of EV and their molecular cargos will contribute to understanding bacterial physiology and to developing therapeutic approaches. Results: Bacillus subtilis were observed to release EV to a similar extent during sporulation as during the vegetative growth phase. However, the two vesicular cargos show qualitatively and quantitatively different proteomes. Among 193 total proteins identified across both samples, 61 were shown to be significantly more abundant in EV shed by sporulating cells, with (log) ratio of spectral counts RSC > 1 and Fisher-exact test FDR < 5 %. Sixty-two proteins were found to be significantly more abundant in EV shed by vegetative cells. Membrane fusion was shown to take place between these EVs and Gram-positive cells. Conclusion: Biogenesis of EV is a continuous process over the entire life cycle of this sporulating bacterium. The formation of EV during sporulation is strongly supported by the delineation of protein content that differs from the proteome of EV formed by vegetative spores. Keywords: Label-free quantification, Bacillus subtilis, Secretome, Sporulation, Extracellular vesicles Background Gram-positive bacteria were thought not to produce EV Extracellular vesicles (EV) are universally produced because they lack outer membranes.
    [Show full text]
  • Mirna Let-7 from TPO(+) Extracellular Vesicles Is a Potential Marker for a Differential Diagnosis of Follicular Thyroid Nodules
    cells Article MiRNA let-7 from TPO(+) Extracellular Vesicles is a Potential Marker for a Differential Diagnosis of Follicular Thyroid Nodules Lidia Zabegina 1,2,3, Inga Nazarova 1,2, Margarita Knyazeva 1,2,3, Nadezhda Nikiforova 1,2, Maria Slyusarenko 1,2, Sergey Titov 4 , Dmitry Vasilyev 1, Ilya Sleptsov 5 and Anastasia Malek 1,2,* 1 Subcellular Technology Lab., N.N. Petrov National Medical Research Center of Oncology, 195251 St. Petersburg, Russia; [email protected] (L.Z.); [email protected] (I.N.); [email protected] (M.K.); [email protected] (N.N.); [email protected] (M.S.); [email protected] (D.V.) 2 Oncosystem Ltd., 121205 Moscow, Russia 3 Institute of Biomedical Systems and Biotechnologies, Peter the Great St. Petersburg Polytechnic University, 195251 St. Petersburg, Russia 4 PCR Laboratory; AO Vector-Best, 630117 Novosibirsk, Russia; [email protected] 5 Department of endocrine surgery, Clinic of High Medical Technologies, St. Petersburg State University N.I. Pirogov, 190103 St. Petersburg, Russia; [email protected] * Correspondence: [email protected]; Tel.: +7-960-250-46-80 Received: 19 July 2020; Accepted: 15 August 2020; Published: 18 August 2020 Abstract: Background: The current approaches to distinguish follicular adenomas (FA) and follicular thyroid cancer (FTC) at the pre-operative stage have low predictive value. Liquid biopsy-based analysis of circulating extracellular vesicles (EVs) presents a promising diagnostic method. However, the extreme heterogeneity of plasma EV population hampers the development of new diagnostic tests. We hypothesize that the isolation of EVs with thyroid-specific surface molecules followed by miRNA analysis, may have improved diagnostic potency.
    [Show full text]
  • Exploring Transcriptomic Landscapes in Red Blood Cells, in Their Extracellular Vesicles and on a Single- Cell Level
    Exploring transcriptomic landscapes in red blood cells, in their extracellular vesicles and on a single- cell level Erja Kerkelä ( erja.kerkela@bloodservice. ) Finnish Red Cross Blood Service https://orcid.org/0000-0002-2923-5300 Jenni Lahtela University of Helsinki, Institute for Molecular Medicine Finland (FIMM) Antti Larjo Finnish Red Cross Blood Service Ulla Impola Finnish Red Cross Blood Service Laura Mäenpää University of Helsinki, Research Programs Unit, Molecular Neurology Pirkko Mattila University of Helsinki, Institute of Molecular Medicine Finland (FIMM) Research article Keywords: erythrocyte, MALAT1, RNA sequencing, transcriptomics, extracellular vesicle Posted Date: September 18th, 2019 DOI: https://doi.org/10.21203/rs.2.14503/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/27 Abstract Background Circulating human red blood cells (RBCs) consist of mature erythrocytes and immature reticulocytes. Being anucleated, RBCs lack typical transcriptomes, but are known to contain small amounts of diverse long transcripts and microRNAs. However, the exact role and importance of these RNAs is lacking. Results To study this further, we explored the transcriptomes of RBCs and extracellular vesicles (EVs) of RBCs using next-generation sequencing. Furthermore, to understand the dynamics of the RBC transcriptome, we performed single-cell RNA sequencing on RBCs. An analysis of the single-cell transcriptomes revealed that approximately 10% of the cells contained detectable levels of mRNA and fell into three subpopulations based on their transcriptomes. Decrease in the mRNA quantity was observed across the populations. Qualitative changes included the differences in the globin transcripts and changes in the expression of ribosomal genes.
    [Show full text]
  • Extracellular Vesicles in Immunomodulation and Tumor Progression
    REVIEW ARTICLE https://doi.org/10.1038/s41590-021-00899-0 Extracellular vesicles in immunomodulation and tumor progression Carolyn Marar1,2,6,7, Bartholomew Starich 1,3,7 and Denis Wirtz 1,3,4,5 ✉ Extracellular vesicles have emerged as prominent regulators of the immune response during tumor progression. EVs contain a diverse repertoire of molecular cargo that plays a critical role in immunomodulation. Here, we identify the role of EVs as media- tors of communication between cancer and immune cells. This expanded role of EVs may shed light on the mechanisms behind tumor progression and provide translational diagnostic and prognostic tools for immunologists. ells communicate via contact-dependent and contact- described the ability of small EVs released by dendritic cells (DCs) independent interactions through the secretion of chemo- to induce tumor suppression in vivo. In 2002, another study elabo- kines, cytokines, growth factors, and associated cell recep- rated on this work to describe a mechanism for indirect T cell stim- C 11 tors. Over the past 30 years, the secretion of EVs has also emerged ulation by DC small EVs . These discoveries established EVs as a as a major mechanism for cell–cell and cell–environment interac- major mechanism of cellular communication and provided a basis tions. These 30- to 5,000-nm lipid-membrane-bound vesicles con- for immune EV research over the past two decades. tain functional proteins, nucleic acids, lipids, and other bioactive DCs are antigen-presenting cells (APCs) that orchestrate the molecules that can modulate the behavior of recipient cells1. immune response against a specific antigen.
    [Show full text]
  • Extracellular Vesicles and Host–Pathogen Interactions: a Review of Inter-Kingdom Signaling by Small Noncoding RNA
    G C A T T A C G G C A T genes Review Extracellular Vesicles and Host–Pathogen Interactions: A Review of Inter-Kingdom Signaling by Small Noncoding RNA Bruce A. Stanton Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, NH 03755, USA; [email protected] Abstract: The focus of this brief review is to describe the role of noncoding regulatory RNAs, including short RNAs (sRNA), transfer RNA (tRNA) fragments and microRNAs (miRNA) secreted in extracellular vesicles (EVs), in inter-kingdom communication between bacteria and mammalian (human) host cells. Bacteria secrete vesicles that contain noncoding regulatory RNAs, and recent studies have shown that the bacterial vesicles fuse with and deliver regulatory RNAs to host cells, and similar to eukaryotic miRNAs, regulatory RNAs modulate the host immune response to infection. Recent studies have also demonstrated that mammalian cells secrete EVs containing miRNAs that regulate the gut microbiome, biofilm formation and the bacterial response to antibiotics. Thus, as evidence accumulates it is becoming clear that the secretion of noncoding regulatory RNAs and miRNAs in extracellular vesicles is an important mechanism of bidirectional communication between bacteria and mammalian (human) host cells. However, additional research is necessary to elucidate how noncoding regulatory RNAs and miRNA secreted in extracellular vesicles mediate inter-kingdom communication. Keywords: outer membrane vesicles (OMV); extracellular vesicles (EVs); bacterial extracellular Citation: Stanton, B.A. Extracellular vesicles (BEV); small non-coding RNA (sRNA); inter-kingdom communication Vesicles and Host–Pathogen Interactions: A Review of Inter-Kingdom Signaling by Small Noncoding RNA. Genes 2021, 12, 1010.
    [Show full text]
  • Radioiodine Labeling and in Vivo Trafficking of Extracellular Vesicles
    www.nature.com/scientificreports OPEN Radioiodine labeling and in vivo trafcking of extracellular vesicles Chae Moon Hong1,2, Prakash Gangadaran1,3, Ji Min Oh1, Ramya Lakshmi Rajendran1, Arunnehru Gopal1, Liya Zhu1 & Byeong‑Cheol Ahn1,2* Biodistribution and role of extracellular vesicles (EVs) are still largely unknown. Reliable tracking methods for EVs are needed. In this study, nuclear imaging using radioiodine were developed and applied for tracking EVs derived from cell lines. EVs were obtained from supernatant of thyroid cancer cell (Cal62) and natural killer cells (NK92‑MI) using sequential ultracentrifuges. Sulfosuccinimidyl‑3‑(4‑ hydroxypheynyl) propionate were labeled to membrane of Cal62 and NK92‑MI cell derived EVs, then the EVs were labeled with radioiodine (I‑131 and I‑125) using pre‑coated iodination tubes (RI‑EVs). In vivo gamma camera images were obtained after intravenous injection of the RI‑EVs, and ex vivo biodistribution study was also performed. EVs were labeled with radioiodine and radiochemical purity of the RI‑EV was more than 98%. Results of nanoparticle tracking analysis and electron microscopy showed that there was no signifcant diference in EVs before and after the radioiodine labeling. After intravenous injection of RI‑EVs to mice, gamma camera imaging well visualized the real‑time biodistribution of the RI‑EVs. RI‑EVs were mainly visualized at liver, spleen, and lung. Nuclear imaging system of EVs derived from thyroid cancer and NK cells using radioiodine labeling of the EVs was established. Thus, this system might be helpful for in vivo tracking of EVs. Extracellular vesicles (EVs) are naturally released from the cell that are delimited by a lipid bilayer and cannot replicate, which do not contain functional nucleus1.
    [Show full text]
  • Extracellular Vesicle-Based Vaccine Platform Displaying Native Viral Envelope Proteins Elicits a Robust Anti-SARS-Cov-2 Response in Mice
    bioRxiv preprint doi: https://doi.org/10.1101/2020.10.28.357137; this version posted October 28, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Extracellular vesicle-based vaccine platform displaying native viral envelope proteins elicits a robust anti-SARS-CoV-2 response in mice K. Polak1*, N. Greze1, M. Lachat1, D. Merle1, S. Chiumento1, C. Bertrand-Gaday2, B. Trentin1, R. Z. Mamoun1*. 5 Affiliations: 1Ciloa SAS, Montpellier, France. 2DMEM, Univ Montpellier, INRAE, Montpellier, France. *Correspondence to: [email protected]; [email protected] 10 Abstract Extracellular vesicles (EVs) emerge as essential mediators of intercellular communication. DNA vaccines encoding antigens presented on EVs efficiently induce T-cell responses and EV-based vaccines containing the Spike (S) proteins of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) are highly immunogenic in mice. Thus, EVs may serve as vaccine platforms against 15 emerging diseases, going beyond traditional strategies, with the antigen displayed identically to the original protein embedded in the viral membrane and presented as such to the immune system. Compared to their viral and pseudotyped counterparts, EV-based vaccines overcome many safety issues including pre-existing immunity against these vectors. Here, we applied our technology in natural EV’s engineering, to express the S proteins of SARS-CoV-2 embedded in the EVs, which 20 mimic the virus with its fully native spikes. Immunizations with a two component CoVEVax vaccine, comprising DNA vector (DNAS-EV) primes, allowing in situ production of Spike harbouring EVs, and a boost using S-EVs produced in mammalian cells, trigger potent neutralizing and cellular responses in mice, in the absence of any adjuvants.
    [Show full text]
  • Extracellular Vesicle Transportation and Uptake by Recipient Cells: a Critical Process to Regulate Human Diseases
    processes Review Extracellular Vesicle Transportation and Uptake by Recipient Cells: A Critical Process to Regulate Human Diseases Zhi Hao Kwok, Chenghao Wang and Yang Jin * Division of Pulmonary and Critical Care Medicine, Department of Medicine, Boston University Medical Campus, Boston, MA 02118, USA; [email protected] (Z.H.K.); [email protected] (C.W.) * Correspondence: [email protected] Abstract: Emerging evidence highlights the relevance of extracellular vesicles (EVs) in modulating human diseases including but not limited to cancer, inflammation, and neurological disorders. EVs can be found in almost all types of human body fluids, suggesting that their trafficking may allow for their targeting to remote recipient cells. While molecular processes underlying EV biogenesis and secretion are increasingly elucidated, mechanisms governing EV transportation, target finding and binding, as well as uptake into recipient cells remain to be characterized. Understanding the specificity of EV transport and uptake is critical to facilitating the development of EVs as valuable diagnostics and therapeutics. In this mini review, we focus on EV uptake mechanisms and specificities, as well as their implications in human diseases. Keywords: extracellular vesicles; uptake specificity; endocytosis 1. Introduction Extracellular vesicles (EVs) are heterogenous, membrane-bound packages containing complex cargos including nucleic acids, lipids, and proteins. While EVs were initially con- Citation: Kwok, Z.H.; Wang, C.; Jin, sidered to be mechanisms for the discharge of cellular wastes [1], increasing evidence has Y. Extracellular Vesicle Transportation implicated EVs as an important mean of intercellular communication via the transference and Uptake by Recipient Cells: A of their cargo contents between cells [2–4]. Over the years, EVs have been broadly classified Critical Process to Regulate Human into two categories, namely exosomes and microvesicles (MVs), according to their physical Processes 2021 9 Diseases.
    [Show full text]
  • Promising Extracellular Vesicle-Based Vaccines Against Viruses, Including SARS-Cov-2
    biology Review Promising Extracellular Vesicle-Based Vaccines against Viruses, Including SARS-CoV-2 Berina Sabanovic †, Francesco Piva †, Monia Cecati and Matteo Giulietti * Department of Specialistic Clinical and Odontostomatological Sciences, Polytechnic University of Marche, 60131 Ancona, Italy; [email protected] (B.S.); [email protected] (F.P.); [email protected] (M.C.) * Correspondence: [email protected]; Tel.: +39-071-2204641; Fax: +39-071-2204609 † Equally contributing authors. Simple Summary: Extracellular vesicles (EVs) allow cell-to-cell communication and can induce a strong immune response, by presenting antigens. EVs can be engineered to display viral antigens and so induce high and specific CD8(+) T cell and B cell reactions, highlighting these antigen-presenting EVs as a novel vaccine strategy. EVs present a low basal immunogenic profile and engineered EVs represent a safe, flexible, and efficient strategy for a virus-free vaccine design. Some biotech companies are developing EV-based vaccines against COVID-19, by displaying the SARS-CoV-2 Spike protein on the exosome surface or by delivering mRNAs of viral proteins through EVs. Abstract: Extracellular vesicles (EVs) are secreted from almost all human cells and mediate intercellu- lar communication by transferring heterogeneous molecules (i.e., DNA, RNAs, proteins, and lipids). In this way, EVs participate in various biological processes, including immune responses. Viruses can hijack EV biogenesis systems for their dissemination, while EVs from infected cells can transfer viral proteins to uninfected cells and to immune cells in order to mask the infection or to trigger a response. Several studies have highlighted the role of native or engineered EVs in the induction of B cell and CD8(+) T cell reactions against viral proteins, strongly suggesting these antigen-presenting Citation: Sabanovic, B.; Piva, F.; EVs as a novel strategy for vaccine design, including the emerging COVID-19.
    [Show full text]
  • Mitochondria As Extracellular Vesicle Cargo in Aging
    www.aging-us.com AGING 2021, Vol. 13, No. 14 Editorial Mitochondria as extracellular vesicle cargo in a ging Nicole Noren Hooten and Michele K. Evans Aging is associated with a state of chronic low-grade report showed an initial decline in ccf-mtDNA into inflammation, termed ‘inflamm-ageing’, that likely middle-age and then a gradual increase after the fifth contributes to many age-related pathologies including decade of life [4]. Individuals greater than 90 years of cardiovascular disease, chronic kidney disease, type 2 age with high levels of ccf-mtDNA had higher levels of diabetes mellitus, cancer and dementia [1]. In fact, the proinflammatory cytokines TNF-a, IL-6, IL-1ra and inflammation-related diseases account for more than RANTES compared to individuals with low levels of 50% of worldwide deaths, stressing the importance of ccf-mtDNA who also had lower levels of these inflammation in driving age-related disease and cytokines [4]. Together these studies indicate that ccf- mortality [1, 2]. Many factors contribute to chronic mtDNA may contribute to systemic chronic inflam- inflammation in the elderly [1]. Cellular damage or mation. However, we are only beginning to understand stress can initiate a release of mitochondrial damage- the molecular details of how ccf-mtDNA exists in the associated molecular patterns (DAMPs). As part of this circulation. Thus far, most studies examine ccf-mtDNA process, mitochondrial DNA (mtDNA) can be released in complex body fluids such as plasma and serum and into the extracellular space as circulating cell-free little is known about the components to which they bind mitochondria DNA (ccf-mtDNA) (Figure 1A).
    [Show full text]
  • Label-Free Characterization of Single Extracellular Vesicles Using Two
    www.nature.com/scientificreports OPEN Label‑free characterization of single extracellular vesicles using two‑photon fuorescence lifetime imaging microscopy of NAD(P)H Janet E. Sorrells1,2, Elisabeth M. Martin2, Edita Aksamitiene1,3, Prabuddha Mukherjee1,3, Aneesh Alex1,3, Eric J. Chaney1, Marina Marjanovic1,2,3 & Stephen A. Boppart1,2,3,4,5,6* The heterogeneous nature of extracellular vesicles (EVs) creates the need for single EV characterization techniques. However, many common biochemical and functional EV analysis techniques lack single EV resolution. Two‑photon fuorescence lifetime imaging microscopy (FLIM) is widely used to functionally characterize the reduced form of nicotinamide adenine dinucleotide and nicotinamide adenine dinucleotide phosphate (NAD(P)H) in cells and tissues. Here, we demonstrate that FLIM can also be used to image and characterize NAD(P)H in single isolated EVs. EVs were isolated using standard diferential ultracentrifugation techniques from multiple cell lines and imaged using a custom two‑photon FLIM system. The presented data show that the NAD(P)H fuorescence lifetimes in isolated cell‑derived EVs follow a wide Gaussian distribution, indicating the presence of a range of diferent protein‑bound and free NAD(P)H species. EV NAD(P)H fuorescence lifetime distribution has a larger standard deviation than that of cells and a signifcantly diferent fuorescence lifetime distribution than the nuclei, mitochondria, and cytosol of cells. Additionally, changes in the metabolic conditions of cells were refected in changes in the mean fuorescence lifetime of NAD(P) H in the produced EVs. These data suggest that FLIM of NAD(P)H could be a valuable tool for EV research.
    [Show full text]